Boston Scientific accounts are for healthcare professionals only.
Join our events
Lunch Symposium
Boston Scientific: Advancing Science for the Future of Interventional Pain Care
Discover the breakthrough innovations and evidence that are shaping the next era of interventional pain therapies.
Monday, May 11
12:45-1:45 pm
Pavilion 5
Lisbon Congress Centre
Presented by Mitch Engle, MD, PhD,* Manny Gage, MD* and Mr. Adam Williams,*
Moderated by: Prof. Dr. Jarek Maciaczyk
Device learning lab
Advancing Spinal Cord Stimulation: Built on Innovation, Focused on the Future
Tuesday, May 12
11:15am-12:15pm
Room 109, Level 1
Lisbon Congress Centre
Presented by Mitch Engle, MD, PhD* and Manny Gage, MD*
These sessions are not included in main event CME/CPD credits.
Clinical and scientific data presentations
Pain management
Three-Year Outcomes Using Fast-Acting Sub-Perception Therapy for Spinal Cord Stimulation: Global Results of a Real-World, Multi-Center Study
Monday, May 11
10:15- 10:20 am
Rapid Fire Presentation Station 3
Presented by Simon Bayerl, MD
Computational Modeling and Clinical Recordings Demonstrate that Novel Dynamic SCS Waveforms Intentionally Generate Patterned Dorsal Column Activity and May Improve Efficacy of SCS
Monday, May 11
5:05 - 6:35pm
Auditorium II
Presented by Ashwin Viswanathan, MD
SOLIS RCT: 2-Year Outcomes of SCS vs. Medical Management in Surgery-Naïve Back Pain Patients
Monday, May 11
5:05 - 6:35pm
Auditorium I
Presented by Mitch Engle, MD, PhD
Spinal Cord Stimulation Alleviates Pain and Restores Sensory and Autonomic Functions in Painful Diabetic Peripheral Neuropathy: Outcomes from the INSPIRE Study
Monday, May 11
5:05 - 6:35pm
Auditorium II
Presented by Jose Paz Solis, MD
Two-Year Outcomes Following Salvage Using a Novel Spinal Cord Stimulation System: Results from a European Multi-Center Study
Tuesday, May 12
4:20 - 5:50pm
Auditorium II
Presented by Philippe Rigoard, MD, PhD
Real-World Long-Term Outcomes in a Chronic Pain Patient European Cohort Undergoing a Single-Stage SCS-Implantation Procedure
Tuesday, May 12
4:20 - 5:50pm
Auditorium II
Presented by Alvise Martini, MD
Spinal Cord Stimulation in Non Reconstructable Critical Limb Ischemia: A Single-Site Long-Term Review of 10-Year Experience
Tuesday, May 12
4:20 - 5:50pm
Auditorium III + IV
Presented by Naoufel Ouerchefani, MD
Three-year Outcomes of Spinal Cord Stimulation Across Multiple Indications: A Prospective, Global, Real-World Registry
Tuesday, May 12
4:20 - 5:50pm
Auditorium III + IV
Thomson et al.
Deep Brain Stimulation
Oral Presentations
Real-World Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control - USA Experience
Real-World Outcomes from a Prospective, Multicenter Deep Brain Stimulation Registry of Essential Tremor Patients
Characterizing Time to Depletion in Multiple-Independent Current-Controlled Rechargeable Implantable Pulse Generators for Deep Brain Stimulation
Tremor Reduction Using DBS: Outcomes of a Real-world, Prospective, Multicenter Essential Tremor Registry
Thursday, May 14
10:30 - 11:30am
Auditorium III + IV
Presented by Dr. Prof. Jan Vesper
†Nalu™ Neurostimulation System
*The noted individual(s) serves as a consultant to Boston Scientific and is compensated for services provided under a consulting agreement.
- Gage E., et al. Rapid Onset of Analgesia during Trial Period Utilizing Fast-Acting Sub-Perception Therapy SCS [Abstract] NANS 2023 Annual Meeting, Jan 12-15, 2023.
- Anitescu M., et al. Utilizing SCS Designed to Engage Surround Inhibition Using Fast-Acting Sub-Perception Therapy (FAST): Prospective, Multicenter, Long-Term Outcomes [Abstract] NANS 2025 Annual Meeting, Jan 30-Feb1, 2025.
- Metzger C, Hammond B, Ferro R, North J, Pyles S, Kranenburg A, Washabaugh E, Goldberg E. Two-year outcomes using fast-acting sub-perception therapy for spinal cord stimulation: results of a real-world multicenter study in the United States. Expert Rev Med Devices. 2025 Jan-Feb;22(2):155-164.
- Bayerl S, Paz-Solis J, Matis G, et al. Two-year outcomes using fast-acting, sub-perception therapy for spinal cord stimulation: a European, real-world, multicenter experience. JCM. 2024;13(22):6999
- Ferro R, North J, Kranenburg A, et al. Automated neural dosing for fast-acting subperception therapy: sustained spinal cord stimulation outcomes from a multicenter study. Pain Ther.2025;14(4):1417-1429.
- Engle MP, Hersel A, Gutierrez G, Khemlani V, Kapural L, et al. (2026) Long-Term Clinical Outcomes (24 Months) of Peripheral Nerve Stimulation in the Treatment of Chronic Pain - COMFORT RCT. Chron Pain Manag 10: 179. DOI: 10.29011/2576-957X.100079
- Fischgrund J, Rhyne A, Macadaeg K, et al. Long-term outcomes following intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 5-year treatment arm results from a prospective randomized double-blind sham-controlled multi-center study. Eur Spine J. 2020;29(8):1925-34. doi.org/10.1007/s00586-020-06448-x
U.S. Federal Government Employees – U.S. Federal Government Employees may be required to obtain approval from their agency’s or institution’s ethics officer or ethics committee or from a supervisor to attend this program. For more details, please contact your ethics officer or supervisor.
Vermont-Licensed HCPs – Vermont law prohibits Boston Scientific from providing any food, meals or refreshments at no charge to health care professionals licensed by and regularly practicing in Vermont. Accordingly, health care professionals licensed by and regularly practicing in Vermont are requested not to partake in any of the food, meals or refreshments offered at this event.
All U.S. Physicians – The U.S. Physician Payment Sunshine Act requires all pharmaceutical, biologics and medical device companies to disclose annually to the U.S. government payments and transfers of value provided to U.S. physicians and teaching hospitals. This includes the value of meals and refreshments provided to U.S. physicians in connection with attending Boston Scientific educational programs.
Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.
Warning: Stimulation modes. Only paresthesia-based stimulation mode has been evaluated for effectiveness in the diabetic peripheral neuropathy (DPN) population.
In the initial subperception RCT (WHISPER Study), subperception stimulation was demonstrated to be safe and effective in patients who have been treated successfully with conventional, paresthesia-inducing stimulation for at least six months. Full stimulation parameter ranges and options for both paresthesia-based and subperception therapy (such as FAST, Contour™ Programming Algorithm, and other programmable parameters) are available for clinician’s use throughout the patient’s experience and treatment with SCS.
Data releases and publications from studies such as FAST, WaveWriter-SOLIS RCT, RELIEF and PRO have all included patients who successfully used subperception therapy from the start of their experience and treatment with SCS.
View Boston Scientific Spinal Cord Stimulator System Indications, Safety, and Warnings
View Boston Scientific Nalu Neurostimulation System Indications, Safety, and Warnings
View Boston Scientific Radiofrequency Ablation Indications, Safety, and Warnings
View Boston Scientific Deep Brain System Indications, Safety, and Warnings
OUS Indications for Use - CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.